Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 33 Carcinoma, Non-Small-Cell Lung 23 Lung Neoplasms 11 Triple Negative Breast Neoplasms 3 Recurrence 3 Esophageal Squamous Cell Carcinoma 3 Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Hodgkin Disease 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Thoracic Neoplasms 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Prostatic Neoplasms 1 Primary Breast Cancer 1 Pathologic Residual Cancer Cells 1 Ovarian Neoplasms 1 Osteosarcoma 1 Nonhematologic Malignancies 1 Non-small Cell Lung Cancer Stage Ⅱ 1 Non-small Cell Lung Cancer Metastatic 1 Neuroblastoma 1 Neoplasms, Connective and Soft Tissue 1 Neoplasm Metastasis 1 NSCLC 1

Interventions

Temozolomide 2 nimotuzumab 1 Vinorelbine 1 Valproic Acid 1 Radiotherapy 1 Everolimus 1 Erlotinib Hydrochloride 1 Drug Therapy 1 Dasatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Diffuse Intrinsic Pontine Glioma × Vinorelbine × Clear all

NCT03620032 2023-12-06

DIPG

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Unknown

Diffuse Intrinsic Pontine Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡